-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, KHOIRG2y5TvczhXw+RDAU3j4CtWWFKjsVx/U2AsixHn+pjgjyBbBX2wuIpLweF59 XrF/6iSnkpzwrYZ5uu0twQ== 0000874015-04-000004.txt : 20040105 0000874015-04-000004.hdr.sgml : 20040105 20040105162006 ACCESSION NUMBER: 0000874015-04-000004 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20040101 FILED AS OF DATE: 20040105 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ISIS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000874015 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330336973 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2292 FARADAY AVE CITY: CARLSBAD STATE: CA ZIP: 92008 BUSINESS PHONE: 7609319200 MAIL ADDRESS: STREET 1: 2292 FARADAY AVE CITY: CARLSBAD STATE: CA ZIP: 92008 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CROOKE STANLEY T CENTRAL INDEX KEY: 0000897667 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19125 FILM NUMBER: 04505242 BUSINESS ADDRESS: STREET 1: C/O ISIS PHARMACEUTICALS INC STREET 2: 2292 FARADAY AVENUE CITY: CARLSBAD STATE: CA ZIP: 92008 BUSINESS PHONE: 6196032301 MAIL ADDRESS: STREET 1: 2292 FARADAY AVENUE CITY: CARLSBAD STATE: CA ZIP: 92008 4 1 edgar.xml PRIMARY DOCUMENT X0201 42004-01-01 0000874015 ISIS PHARMACEUTICALS INC ISIS 0000897667 CROOKE STANLEY T 2292 FARADAY AVENUE CARLSBAD CA 92008 1100Chairman, CEO, PresidentEmployee Stock Option (right to buy)6.812004-01-022004-01-024A0800006.81A2008-01-022014-01-01Common Stock8000080000DEmployee Stock Option (right to buy)6.812004-01-022004-01-024A047256.81A2008-01-022014-01-01Common Stock47254725IBy wife25% of the shares subject to the option will vest and become ex ercisable on 1-2-05. Thereafter, the remaining shares subject to the option vest and become exercisable in 36 equal monthly installments, at the rate of 20,000 shares per year. The option is exercisable as to 0 shares on 1-2-04.25% of the shares subject to the option will vest and become exercisable on 1-2-05. Thereafter, the remaining shares subject to the option vest and become exercisable in 36 equal monthly installments, at the rate of 1,181 shares per year. The option is exercisable as to 0 shares on 1-2-04.Stanley T Crooke2004-01-05 -----END PRIVACY-ENHANCED MESSAGE-----